Amundi
AXSM icon

Amundi’s Axsome Therapeutics AXSM Stock Holding History

Amundi’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$498K Buy
+2,945
New +$509K ﹤0.01% 1548
2022
Q4 		– Sell
-3,053
Closed -$141K – 1902
2022
Q3 		$141K Hold
3,053
– – ﹤0.01% 1503
2022
Q2 		$135K Buy
+3,053
New +$96.6K ﹤0.01% 1404
2021
Q3 		– Sell
-2,800
Closed -$189K – 1568
2021
Q2 		$189K Buy
+2,800
New +$168K ﹤0.01% 1387

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Amundi's AXSM Position: Q1 2026 in Review

Amundi opened a new position in Axsome Therapeutics (AXSM) in Q1 2026: 2,945 shares worth $498K. The stake represents ﹤0.01% of the portfolio and ranks #1548 among its holdings. This is a return to the name: Amundi previously reported a position in AXSM as recently as Q3 2022.

Amundi first reported a position in AXSM in Q2 2021 and has held it in 4 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Amundi held 2,945 shares of Axsome Therapeutics worth $498K as of Q1 2026.
  • Axsome Therapeutics was a new Amundi position in Q1 2026.
  • Axsome Therapeutics made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1548 holding.
  • Amundi first reported a position in Axsome Therapeutics in Q2 2021 and has held it in 4 quarters since.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.